Oncologists demand more education on the use of biosimilars: ESMO takes action

(European Society for Medical Oncology) Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines -- but they are also expensive.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news